Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding and thromboembolic outcomes after femoral fracture surgery
IRCT20180422039382N4Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in femoral fracture (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Blood volume lost, Amount of blood received and 2 more. Started Dec 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20180422039382N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180422039382N4.